A Study of Brenipatide in Participants With Alcohol Use Disorder

Clinical trial NCT07219953 · RECRUITING

Trial details

NCT number: NCT07219953
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alcohol Use Disorder

Start date: 2025-10-16
Primary completion: 2028-04-01
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.